The Danish multinational pharmaceutical company Novo Nordisk has been slammed by MSF (Doctors Without Borders) for the shortage of insulin pens in South Africa. The insulin manufacturer has been a long-time supplier of insulin pens but last year it decided not to bid for the new tender which began in May 2024. Because no other company applied for the tender, public health facilities across the country have been running low, with shortages of the product since earlier this year. Lester Kiewit speaks to GroundUp journalist Jesse Copelyn to find out the details behind the story.